000 01202 a2200325 4500
005 20250514024722.0
264 0 _c20020408
008 200204s 0 0 fre d
022 _a1297-9589
024 7 _a10.1016/s1297-9589(01)00265-x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aEspiƩ, M
245 0 0 _a[Adjuvant treatment for breast cancer. Results of the consensus conference of Saint-Gall (February 2001)].
_h[electronic resource]
260 _bGynecologie, obstetrique & fertilite
_cJan 2002
300 _a86-8 p.
_bdigital
500 _aPublication Type: Consensus Development Conference; Journal Article; Review
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aBreast Neoplasms
_xtherapy
650 0 4 _aCombined Modality Therapy
650 0 4 _aEstrogen Antagonists
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMastectomy
650 0 4 _aPrognosis
650 0 4 _aRadiotherapy
650 0 4 _aTamoxifen
_xtherapeutic use
700 1 _aCottu, P H
773 0 _tGynecologie, obstetrique & fertilite
_gvol. 30
_gno. 1
_gp. 86-8
856 4 0 _uhttps://doi.org/10.1016/s1297-9589(01)00265-x
_zAvailable from publisher's website
999 _c11783041
_d11783041